Back to Trades
Sundaram Preethi
Chief Strategy OfficerCIK 0001872422
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 4
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Sundaram Preethi, Chief Strategy Officer, has filed 4 SEC reports (2025–2026), all concentrated in CATALYST PHARMACEUTICALS, INC. (CPRX), totaling $14.5M in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
4 loaded
| Jul 17 | CPRX CATALYST PHARMACEUTICALS, INC. | Sundaram Preethi | Chief Strategy Officer | Disposed | $12.1M |
| Dec 30 | CPRX CATALYST PHARMACEUTICALS, INC. | Sundaram Preethi | Chief Strategy Officer | Exercise | $0 |
| Dec 10 | CPRX CATALYST PHARMACEUTICALS, INC. | Sundaram Preethi | Chief Strategy Officer | Exercise | $0 |
| Nov 24 | CPRX CATALYST PHARMACEUTICALS, INC. | Sundaram Preethi | Chief Strategy Officer | Exercise | $2.4M |
4 filings